Skip to main content

New Products

  • Dermablend announces new tool to cover scars, unwanted tattoos

    NEW YORK — Dermablend announced on Wednesday the new Quick-Fix Illuminator, a multipurpose concealer and highlighter that brightens the complexion of the skin with the click of a pen.

  • Gerber introduces meals for toddlers

    FLORHAM PARK, N.J. — Nestle's Gerber division has introduced a line of mix-and-match foods for toddlers, the company said Wednesday.

    Gerber Products Co. announced the introduction of Gerber Graduates 2+ Kid Selects, designed to offer toddlers ages 2 years and older a range of protein, vegetable and grain options in order to help them make nutritious choices and master skills like the use of a fork and spoon.

  • Amneal ships opioid-dependence drug

    BRIDGEWATER, N.J. — Amneal Pharmaceuticals has started shipping a drug used to treat opioid dependence, the company said Tuesday.

    The generic drug maker announced the shipment of buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablets in the 2-mg/0.5-mg and 8-mg/2-mg strengths. The Food and Drug Administration approved the drug in February.

    The drug includes a risk evaluation and mitigation strategy, or REMS, a program required by the FDA to ensure that its benefits outweigh its risks.

  • Dr. Reddy's launches generic cancer drug

    HYDERABAD, India — Generic drug maker Dr. Reddy's Labs has launched a drug used to treat certain cancers, the company said Tuesday.

    Dr. Reddy's announced the launch of injectable zoledronic acid in the 4-mg-per-5-mL strength. The launch followed the Food and Drug Administration's approval of the drug.

    The drug is a generic version of Novartis' Zometa. The drug is used to treat cancers that have spread to the bones and multiple myeloma.

    CORRECTION: An earlier version of this story misstated the strength of the drug. The story has been corrected.

  • Ranbaxy to market antidepressant drug

    PRINCETON, N.J. — Ranbaxy Labs will market a drug for depression under an agreement with another company, the drug maker said Tuesday.

    Ranbaxy said it had entered an in-licensing agreement with Alembic Pharmaceuticals to market desvenlafaxine base extended-release tablets. Alembic is the sponsor of a new drug application filed with the Food and Drug Administration for the drug, which is bioequivalent to Pfizer's Pristiq. Pristiq had sales of $590 million during the 12-month period that ended in January.

  • Abbott to launch Kidz ZonePerfect bars in April

    ABBOTT PARK, Ill. — Abbott on Monday introduced a new line of nutrition bars for active kids branded Kidz ZonePerfect. The new bars are formulated with 5 g of protein, 23 vitamins and minerals, and 3 g of fiber.

  • Chummies reinvents the classic friendship bracelet

    CHICAGO — Chummies, an innovative friendship bracelet, hit the market on Tuesday. The silicone, latex-free interlocking bracelets are sold in pairs and can be pulled apart to give to various close friends, or "chums."

  • Red Bull Editions hit retail shelves

    SANTA MONICA, Calif. — Red Bull Energy on Monday introduced nationwide three new flavors: cranberry, lime and blueberry. In new red, silver and blue cans, the Editions from Red Bull provide the same energy and effect of the original, but with a taste for every palate.

X
This ad will auto-close in 10 seconds